Biographies
Board of Director Biographies
Tony Shum, Chairman
Mr. Shum is a business development executive with the global banking group HSBC. Mr. Shum is a Chartered Accountant and has worked for Deloitte & Touche in Canada and Price Waterhouse in Hong Kong. After leaving public practice, Mr. Shum joined The Walt Disney Company where he helped to establish The Disney Channel in the Asia Pacific region. He has also worked for a private investment firm and has consulted on business development strategy in Asia Pacific and in Europe for businesses ranging from start up ventures to multi-national corporations such as The Walt Disney Company, BBC Worldwide and British Telecom.
Robert Cheney
Mr. Cheney was appointed as CEO on August 31, 2007. He has served as a director of the Company since February 2006. Mr. Cheney is a private investor with experience investing in early stage and growth companies. Previously, Mr. Cheney was the founding partner of a Hong Kong based venture capital investment firm. Prior to his business career Mr. Cheney was a corporate lawyer qualified to practice in Hong Kong, Britain and Canada. Mr. Cheney received his law degree from the University of British Columbia, Canada.
Peter Wong, MD
Dr. Wong has served as a director of the Company since March 2010. Since July 1994, Dr. Wong has been a professor at the University of British Columbia, Faculty of Medicine with a specialization in pediatric clinical neurophysiology. Dr. Wong has also been Director at the Department of Diagnostic Neurophysiology in the Children’s Hospital Medical Center, Harvard Medical School since 1981. Dr. Wong received his training in medicine from McMaster University and completed his research fellowships at the University of California, San Diego and at Children’s Hospital Medical Center, Harvard Medical School, in Boston.
Sung Chun, MD
Dr. Sung H. Chun has been our Chief Medical Officer since November 2007. Since May 2004, Dr. Chun has been the Director of Cardiac Arrhythmia Service in the Palo Alto Medical Foundation. From July, 1997 to April, 2004, Dr. Chun was the Associate Director of Cardiac Arrhythmia Service, Director of Pacemaker Service, as well as the Clinical Assistant Professor (Cardiovascular) in the Stanford University School of Medicine. From September 2001 to April 2004, Dr. Chun was the Program Director of Cardiac Electrophysiology Fellowship of the Stanford University of Medicine. Dr. Chun received a B.S. in Medical Microbiology from Stanford University and M.D. from George Washington University School of Medicine. He did his cardiovascular medicine and cardiac electrophysiology fellowship training at Stanford University Medical Center. Dr. Chun is currently a Board of Director of the Beautiful Mind Ensemble Charity Organization, a member of the Editorial & Advisory Committee, the Japanese Journal of Arrhythmia, and the editorial reviewer for Kluwer Academic Publishers.
Richard Gaston, MD
Dr. Gaston has been our director since October 2007. He retired in 2006 from clinical practice as a Board certified cardiologist for over 25 years. From 1981 to 2006, Dr. Gaston practiced as a cardiologist in Petaluma, California and played a major role in establishing state of the art intensive care unit at the Petaluma Valley Hospital in the 1980’s. From 1997 to 2003, Dr. Gaston was also the biotechnology and pharmaceutical analyst of AmeriCal Securities in San Francisco, California with a prominent role in selling Imatron Inc. to GE Healthcare. Dr. Gaston received an A.B. in Psychology from Stanford University, M.D. from University of Michigan, Internship and Medical Residency from University of Utah and Cardiology Fellowship from Michigan State University.
Phillip Radlick, PhD
Dr. Radlick has been one of our directors since November 1994. Dr. Radlick is currently and independent consultant in the healthcare industry. Dr. Radlick served as President and Chief Executive Officer of Lipid Sciences, Inc., a publicly held biotechnology company, from June 2000 until October 2002. Dr. Radlick was our President and Chief Executive Officer from November 1994 to June 2000. Prior to joining us, from November 1992 until October 1994, Dr. Radlick was the President and Chief Executive Officer of Hepatix, Inc., a start-up medical device company. From November 1986 until November 1992, Dr. Radlick was the President of Edward's Cardiovascular Surgery Division, a division of Baxter Healthcare responsible for the development, manufacture and sale of cardiovascular products. Dr. Radlick received a B.S. in Chemistry and a Ph.D. in Organic Chemistry from the University of California, Los Angeles.
Executive Officers
-
Robert Cheney